Cadila Healthcare Ltd., incorporated in the year 1995, is a Large Cap company (having a market cap of Rs 63031.83 Crore) operating in Pharmaceuticals sector.
Financials
For the quarter ended 31-03-2021, the company reported a Consolidated Total Income of Rs 3806.40 Crore, down -.44 % from last quarter Total Income of Rs 3823.10 Crore and up .26 % from last year same quarter Total Income of Rs 3796.40 Crore. Company reported net profit after tax of Rs 731.60 Crore in latest quarter.
Investment Rationale
The brokerage remains positive on CDH on the back of improving growth prospects in DF, work-in-progress on innovative as well as Complex Generic products, and sharp reduction in net debt.
Promoter/FII Holdings
Promoters held 74.9 per cent stake in the company , FIIs held 5.2 per cent, DIIs 11.5 per cent and public and others 8.4 per cent.
(Views and recommendations given in this section are the analysts’ own and do not represent those of ETMarkets.com. Please consult your financial adviser before taking any position in the stock/s mentioned.)
